Cti biopharma corp

Major-Pharmaceuticals

CTIC


3101 Western Avenue
Seattle , WA 98121

Executive/
Director

Price

  • Last Close
  • $ 9.09
    $ +0 0 %
    Jun 23, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 11,420,980
  • Market Cap Full
  • $ 1.2B
  • Shares Outstanding
  • 131.9M
    May 4, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -23.3% -56.8% 2.9% 45.5% 32.9% -5% -14.3% 88.3% -30.1% -
Q2 7.7% -36% -21.2% 28.4% -13.6% 4% -9.4% 27.8% 116.4% -
Q3 -25.1% 10% -3.6% -58.7% -1.1% 8% 18% -2.5% - -
Q4 -15.8% 9.1% -15.2% -65.2% 84.3% 32.2% -15.9% 3.3% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -8% -1.3% -23.1% 15.7% 86.2% 0.4% - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    24%-48%-67%-34%-73%122%99%-23%142%51%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 0.16 0.01 0.71 -0.08 -0.19 -0.2 -0.23 -0.37
Q2 0.19 0.07 0.03 -0.2 -0.19 -0.19 -0.21 -0.21
Q3 0.19 0.10 0.28 -0.26 -0.17 -0.15 -0.26 -0.13
Q4 0.13 0.23 0.33 0.02 -0.14 -0.2 -0.39 -0.1
A 0.7 0.4 1.4 -0.5 -0.7 -0.7 -1.1 -0.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 58 73.7 76.7 99.9 131.8
Jun 58 58 73.7 93.3 109 131.9
Sep 58 58 73.7 93.3 114.4 -
Dec 58 58 73.8 96.7 126.9 -

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover - - - - 0.9
Fixed Asset Turnover - 0.3 3.6 3.2 7.2
Total Asset Turnover - 0.1 0.3 0.5 0.9
Leverage
Debt Ratio - 0.1 0.1 0.3 0.2
Debt – Equity Ratio - 0.3 0.2 0.8 1.5
Interest Coverage -10.2 58.9 9.4 -7.2 -17.3
Equity multiplier 0.1 0.6 0.1 0.5 1